Daniel Teper

Daniel Gedeon Teper is the founder of Novagali Pharma SA, founded in 1999.
Dr. Teper was the founder of Immune Pharmaceuticals, Inc., founded in 2010, and served as Director from 2017 to 2018.
Dr. Teper is the founder of Cytovia Therapeutics, Inc., founded in 2019, and serves as Chairman since 2023.
Dr. Teper is also the founder of Vector Therapeutics, Inc.,Wintech Pharmaceuticals..
Dr. Teper is currently President, Chief Executive Officer & Director at Cytovia, Inc. (Massachusetts).
Dr. Teper is Chief Executive Officer & Director at NAYA Therapeutics, Inc. Dr. Teper is Chief Executive Officer & Director at Cytovia, Inc. Dr. Teper is Chairman, Chief Executive & Financial Officer at Oxygen Therapy, Inc. since 2018.
Dr. Teper is Member-Supervisory Board at Crossject SA since 2023.
Dr. Teper is Managing Partner at AA & Sons starting 2025.
Former positions include Vice Chairman at Phoenix BioPharm, Inc. President & Director at INVO Fertility, Inc. from 2024 to 2025.
Managing Director at Bionest Partners LLC.
Global President at Havas Life Paris SA from 1996 to 1999.
Senior Vice President-Business Development at SoftWatch, Inc. Senior Vice President & Head-Marketing & Sales at GlaxoSmithKline LLC from 1990 to 1992.
Partner at Iso Healthcare Consulting.
President & Chief Operating Officer at Laboratoires Delagrange.
Education includes a doctorate from Université Paris-Saclay in 1983 and an MBA from INSEAD in 1984.